Skip to main content
. 2021 May 19;10(9):1288–1303. doi: 10.1002/sctm.21-0021

FIGURE 3.

FIGURE 3

Sources of human MSCs used in clinical trials of immune/inflammatory diseases. A, Number of trials using different tissue sources of human MSCs as well as MSC‐derived products, including exosomes and conditioned medium. B, Number of trials using autologous or allogenic source of human MSCs or MSC‐derived products. Data accessed on March 2021 from the NIH Clinical Trial website (https://ClinicalTrials.gov/)